58 related articles for article (PubMed ID: 31039363)
1. Blocking CXCR3 with AMG487 ameliorates the blood-retinal barrier disruption in diabetic mice through anti-oxidative.
Wang H; Li J; Zhong P; Wang S; Zhang L; Yang R; Wu D; Chen M; Ji A; Li Y; Wang J
Life Sci; 2019 Jul; 228():198-207. PubMed ID: 31039363
[TBL] [Abstract][Full Text] [Related]
2. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of Curcumin on the Tight Junction Integrity and Cellular Senescence in Human Retinal Pigment Epithelium of Early Diabetic Retinopathy.
Cheng YW; Huang YC; Chang KF; Huang XF; Sheu GT; Tsai NM
J Physiol Investig; 2024 May; 67(3):107-117. PubMed ID: 38857204
[TBL] [Abstract][Full Text] [Related]
4. A CNS-specific hypomorphic Pdgfr-beta mutant model of diabetic retinopathy.
Jadeja S; Mort RL; Keighren M; Hart AW; Joynson R; Wells S; Potter PK; Jackson IJ
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3569-78. PubMed ID: 23633653
[TBL] [Abstract][Full Text] [Related]
5. LAMP1 controls CXCL10-CXCR3 axis mediated inflammatory regulation of macrophage polarization during inflammatory stimulation.
Ye Y; Li L; Kang H; Wan Z; Zhang M; Gang B; Liu J; Liu G; Gu W
Int Immunopharmacol; 2024 May; 132():111929. PubMed ID: 38555817
[TBL] [Abstract][Full Text] [Related]
6. Alleviate oxidative stress in diabetic retinopathy: antioxidant therapeutic strategies.
Gao J; Tao L; Jiang Z
Redox Rep; 2023 Dec; 28(1):2272386. PubMed ID: 38041593
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.
Wu Y; Tang L; Chen B
Oxid Med Cell Longev; 2014; 2014():752387. PubMed ID: 25180070
[TBL] [Abstract][Full Text] [Related]
8. Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy.
Li C; Miao X; Li F; Wang S; Liu Q; Wang Y; Sun J
Oxid Med Cell Longev; 2017; 2017():9702820. PubMed ID: 28265339
[TBL] [Abstract][Full Text] [Related]
9. Syn3, a newly developed cyclic peptide and BDNF signaling enhancer, ameliorates retinal ganglion cell degeneration in diabetic retinopathy.
Li KR; Huan MJ; Yao J; Li JJ; Cao Y; Wang S; Naik MT; Fang Y; Marshall J; Lan CG; Cao C
Protein Cell; 2024 May; ():. PubMed ID: 38743493
[No Abstract] [Full Text] [Related]
10. Structure basis for the modulation of CXC chemokine receptor 3 by antagonist AMG487.
Jiao H; Pang B; Chiang YC; Chen Q; Pan Q; Ren R; Hu H
Cell Discov; 2023 Nov; 9(1):119. PubMed ID: 38012179
[No Abstract] [Full Text] [Related]
11. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance.
Bakheet SA; Ansari MA; Nadeem A; Attia SM; Alhoshani AR; Gul G; Al-Qahtani QH; Albekairi NA; Ibrahim KE; Ahmad SF
Cell Signal; 2019 Dec; 64():109395. PubMed ID: 31449849
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Immunological Effects of CXCR3 Inhibitor AMG487 on Dendritic Cells.
Qin C; Liu H; Tang B; Cao M; Yu Z; Liu B; Liu W; Dong Y; Ren H
Arch Immunol Ther Exp (Warsz); 2020 Apr; 68(2):11. PubMed ID: 32239302
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile.
Bakheet SA; Alrwashied BS; Ansari MA; Nadeem A; Attia SM; Alanazi MM; Aldossari AA; Assiri MA; Mahmood HM; Al-Mazroua HA; Ahmad SF
Immunol Lett; 2020 Sep; 225():74-81. PubMed ID: 32590119
[TBL] [Abstract][Full Text] [Related]
14. CXCR3 antagonist AMG487 inhibits glucocorticoid-induced tumor necrosis factor-receptor-related protein and inflammatory mediators in CD45 expressing cells in collagen-induced arthritis mouse model.
Bakheet SA; Alrwashied BS; Ansari MA; Nadeem A; Attia SM; Assiri MA; Alqahtani F; Ibrahim KE; Ahmad SF
Int Immunopharmacol; 2020 Jul; 84():106494. PubMed ID: 32304993
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro.
Sun B; Luo X; Yang C; Liu P; Yang Y; Dong X; Yang Z; Xu J; Zhang Y; Li L
Stem Cells Int; 2019; 2019():8035076. PubMed ID: 31885626
[TBL] [Abstract][Full Text] [Related]
16. Diabetic retinopathy: Involved cells, biomarkers, and treatments.
Ren J; Zhang S; Pan Y; Jin M; Li J; Luo Y; Sun X; Li G
Front Pharmacol; 2022; 13():953691. PubMed ID: 36016568
[TBL] [Abstract][Full Text] [Related]
17. Protective limb remote ischemic post-conditioning against high-intraocular-pressure-induced retinal injury in mice.
Zhu QJ; Zhang L; Lyu SY; Cui ZJ; Jiang ES; Wang J
Int J Ophthalmol; 2022; 15(4):560-567. PubMed ID: 35450174
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Roles of CXCL10 in Experimental Autoimmune Prostatitis by Modulating Macrophage Chemotaxis and Cytokine Secretion.
Hua X; Ge S; Zhang M; Mo F; Zhang L; Zhang J; Yang C; Tai S; Chen X; Zhang L; Liang C
Front Immunol; 2021; 12():706027. PubMed ID: 34659199
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes.
Javeed N; Her TK; Brown MR; Vanderboom P; Rakshit K; Egan AM; Vella A; Lanza I; Matveyenko AV
Cell Rep; 2021 Aug; 36(8):109613. PubMed ID: 34433033
[TBL] [Abstract][Full Text] [Related]
20. The innate immune system in diabetic retinopathy.
Pan WW; Lin F; Fort PE
Prog Retin Eye Res; 2021 Sep; 84():100940. PubMed ID: 33429059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
